17.9 months, HR = 0.67), whereas OS in the ITT populations did not reach statistical significance [ 14 ].
← all excerpts
Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything.
1
—
—
17.9 months, HR = 0.67), whereas OS in the ITT populations did not reach statistical significance [ 14 ].